Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hay

Showing results (631-640 of 655) with videos related to

Pageof 66
Sort By:
Cell Reports. Medicine|December 1, 2022
Tfh cells and the germinal center are required for memory B cell formation & humoral immunity after ChAdOx1 nCoV-19 vaccinationWilliam S Foster, Jia Le Lee, Nazia Thakur, et al.
Oncoimmunology|September 14, 2016
Targeting CD73 in the tumor microenvironment with MEDI9447Carl M Hay, Erin Sult, Qihui Huang, et al.
Annals of the Rheumatic Diseases|November 1, 2019
Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary careEdward Roddy, Kris Clarkson, Milica Blagojevic-Bucknall, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 8, 2001
Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol for a controlled clinical trial developed by consensus of an international study group. Part two: design of the studyA Bauhofer, W Lorenz, B Stinner, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 2, 2024
Primaquine-5,6-Orthoquinone Is Directly Hemolytic to Older G6PD Deficient RBCs in a Humanized Mouse ModelKarolina H Dziewulska-Cronk, Julie A Reisz, Ariel M Hay, et al.
Plos One|July 21, 2017
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adultsSusan P Buchbinder, Nicole A Grunenberg, Brittany J Sanchez, et al.
Oncogene|September 13, 2024
Multifocal, multiphenotypic tumours arising from an MTOR mutation acquired in early embryogenesisClarissa N Pacyna, Madhanagopal Anandapadamanaban, Kevin W Loudon, et al.
Applications in Plant Sciences|August 2, 2021
The best of both worlds: Combining lineage-specific and universal bait sets in target-enrichment hybridization reactionsKasper P Hendriks, Terezie Mandáková, Nikolai M Hay, et al.
The Journal of Clinical Investigation|July 31, 2020
Complement activation on endothelium initiates antibody-mediated acute lung injurySimon J Cleary, Nicholas Kwaan, Jennifer J Tian, et al.
NPJ Aging and Mechanisms of Disease|July 2, 2021
Two separate, large cohorts reveal potential modifiers of age-associated variation in visual reaction time performanceJ S Talboom, M D De Both, M A Naymik, et al.
Pageof 66

Showing results (631-640 of 655) with videos related to

Sort By:
Pageof 66
Cell Reports. Medicine|December 1, 2022
Tfh cells and the germinal center are required for memory B cell formation & humoral immunity after ChAdOx1 nCoV-19 vaccinationWilliam S Foster, Jia Le Lee, Nazia Thakur, et al.
Oncoimmunology|September 14, 2016
Targeting CD73 in the tumor microenvironment with MEDI9447Carl M Hay, Erin Sult, Qihui Huang, et al.
Annals of the Rheumatic Diseases|November 1, 2019
Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary careEdward Roddy, Kris Clarkson, Milica Blagojevic-Bucknall, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 8, 2001
Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol for a controlled clinical trial developed by consensus of an international study group. Part two: design of the studyA Bauhofer, W Lorenz, B Stinner, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 2, 2024
Primaquine-5,6-Orthoquinone Is Directly Hemolytic to Older G6PD Deficient RBCs in a Humanized Mouse ModelKarolina H Dziewulska-Cronk, Julie A Reisz, Ariel M Hay, et al.
Plos One|July 21, 2017
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adultsSusan P Buchbinder, Nicole A Grunenberg, Brittany J Sanchez, et al.
Oncogene|September 13, 2024
Multifocal, multiphenotypic tumours arising from an MTOR mutation acquired in early embryogenesisClarissa N Pacyna, Madhanagopal Anandapadamanaban, Kevin W Loudon, et al.
Applications in Plant Sciences|August 2, 2021
The best of both worlds: Combining lineage-specific and universal bait sets in target-enrichment hybridization reactionsKasper P Hendriks, Terezie Mandáková, Nikolai M Hay, et al.
The Journal of Clinical Investigation|July 31, 2020
Complement activation on endothelium initiates antibody-mediated acute lung injurySimon J Cleary, Nicholas Kwaan, Jennifer J Tian, et al.
NPJ Aging and Mechanisms of Disease|July 2, 2021
Two separate, large cohorts reveal potential modifiers of age-associated variation in visual reaction time performanceJ S Talboom, M D De Both, M A Naymik, et al.
Pageof 66